- Home
- RPTX vs CGO Comparison
RPTX vs CGO Comparison
Compare RPTX & CGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.61
Company Overview
Basic Information| Metric | RPTX | CGO |
|---|---|---|
| Founded | 2016 | 2004 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.4M | 114.5M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | RPTX | CGO |
|---|---|---|
| Price | $2.61 | $11.39 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $3.00 | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 34.7K |
| Earning Date | 11-14-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.25% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $11,870,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2,122.22 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.89 | $7.90 |
| 52 Week High | $2.66 | $10.93 |
Technical Indicators
Market Signals| Indicator | RPTX | CGO |
|---|---|---|
| Relative Strength Index (RSI) | 76.16 | 48.87 |
| Support Level | $2.56 | $11.32 |
| Resistance Level | $2.66 | $11.63 |
| Average True Range (ATR) | 0.06 | 0.14 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 90.57 | 61.14 |
Price Performance
Historical Comparison RPTX
CGO
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
About CGO Calamos Global Total Return Fund
Calamos Global Total Return Fund is a closed-end management investment company. The fund's investment objective is to provide total return through a combination of capital appreciation and current income. The fund invests in equities, convertible securities, and high-yield corporate bonds.